Acquiring Company
Lifeward
Acquired Company
Oratech Pharmaceuticals
MarlboroughNew YorkBiotechnologyHealth CareMedicalBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
Lifeward has completed its acquisition of Oratech Pharmaceuticals for approximately $47 million on March 25, 2026. The deal included the issuance of shares, warrants, and convertible notes. This acquisition is part of Lifeward's strategy to enhance its offerings in mobility solutions. The company recently secured additional funding shortly after finalizing the acquisition.
Quick answer
Lifeward is acquiring Oratech Pharmaceuticals for $47 million, announced April 3, 2026. Lifeward is based in Marlborough, Massachusetts, United States.
- How much did Lifeward pay for Oratech Pharmaceuticals?
- The reported deal value is $47 million.
- What does Lifeward do?
- Lifeward is a medical device manufacturer specializing in mobility-related solutions.
- Where are Lifeward and Oratech Pharmaceuticals based?
- Lifeward is based in Marlborough, Massachusetts, United States. Oratech Pharmaceuticals is based in New York, New York, United States.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Eli Lilly to acquire Ajax Therapeutics for $2.3B, $2.3B (April 27, 2026)
- Lupin completes acquisition of VISUfarma (April 2, 2026)
- Eli Lilly to acquire Centessa Pharmaceuticals (March 31, 2026)
- GLAUKOS Corp acquires Mobius Therapeutics for $12.4M, $12M (February 23, 2026)
- Sensei Biotherapeutics acquires Faeth Therapeutics (February 18, 2026)
- Angelini Pharma acquires Catalyst Pharmaceuticals for $4.1B, $4.1B (May 7, 2026)
Who to call at Lifeward, and when
When Lifeward changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Lifeward raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lifeward, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lifeward. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lifeward makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Oratech Pharmaceuticals?
Oratech Pharmaceuticals was acquired by Lifeward, based in Marlborough. The deal was reported on April 3, 2026. Lifeward is a medical device manufacturer specializing in mobility-related solutions. Their products include the ReWalk Personal Exoskeleton and AlterG Anti-Gravity Systems. Lifeward is publicly traded (LFWD) and operates in Biotechnology.
When did Lifeward acquire Oratech Pharmaceuticals?
Lifeward's acquisition of Oratech Pharmaceuticals was reported on April 3, 2026. Lifeward has completed its acquisition of Oratech Pharmaceuticals for approximately $47 million on March 25, 2026. The deal included the issuance of shares, warrants, and convertible notes. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Oratech Pharmaceuticals do?
Oratech Pharmaceuticals is a subsidiary of Oramed Pharmaceuticals. The company develops medical technology aimed at protecting proteins in medications and enhancing their absorption in the body. It is privately held, operating in Biotechnology, and is based in New York.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.